Patritumab deruxtecan

Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) composed of a fully human anti-HER3 IgG1 monoclonal antibody and a cytotixic topoisomerase I inhibitor. Patritumab deruxtecan shows anticancer activity.
Supplier Selleck Chemicals
Product # D4004
Sku # D4004-1mg*5
Pricing 1mg*5, $2890.00
Feedback